Xconomy’s Digital Events →
Verdezyne pilot plant, used to make bio-based adipic acid
Sponsored · Whitepaper
How a patient-centric, technology-driven approach can broaden access to research and reach patients regardless of geography, ethnicity, sex, or gender
New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
© 2007-2022, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.